14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

$2.35 (0%)

Volume: 20.156M

Closed: May 23, 2022

Hollow Logo Score: -5.408

Chimerix Stock Forecast

BUY SELL NASDAQ:CMRX
$2.35 (0%)

Volume: 20.156M

Closed: May 23, 2022

Score Hollow Logo -5.408

Chimerix Stock Forecast NASDAQ:CMRX

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-17 368.09% HC Wainwright & Co. $24.00 $11.00 Maintains Buy
2021-12-22 921.28% HC Wainwright & Co. $21.00 $24.00 Maintains Buy
2021-11-22 793.62% HC Wainwright & Co. $19.00 $21.00 Maintains Buy
2021-06-07 708.51% HC Wainwright & Co. $18.00 $19.00 Maintains Buy
2021-05-06 665.96% HC Wainwright & Co. $16.00 $18.00 Maintains Buy
2021-04-29 751.06% Maxim Group $20.00 Initiates Coverage On Buy
2021-03-31 495.74% Wedbush $14.00 Initiates Coverage On Outperform
2021-03-31 793.62% Jefferies $21.00 Initiates Coverage On Buy
2021-01-11 580.85% HC Wainwright & Co. $7.00 $16.00 Maintains Buy

CMRX Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -37.08% during the next 3 months and, with a 90% probability hold a price between $0.91 and $2.74 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-25 $1.41 $2.86 $4.31
2022-05-26 $1.37 $2.82 $4.27
2022-05-27 $1.32 $2.78 $4.23
2022-05-31 $1.28 $2.73 $4.19
2022-06-01 $1.24 $2.69 $4.14
2022-06-02 $1.20 $2.65 $4.10
2022-06-03 $1.16 $2.61 $4.06
2022-06-06 $1.11 $2.57 $4.02
2022-06-07 $1.07 $2.52 $3.97
2022-06-08 $1.03 $2.48 $3.93
2022-06-09 $0.99 $2.44 $3.89
2022-06-10 $0.95 $2.40 $3.85
2022-06-13 $0.90 $2.35 $3.81
2022-06-14 $0.86 $2.31 $3.76
2022-06-15 $0.82 $2.27 $3.72
2022-06-16 $0.78 $2.23 $3.68
2022-06-17 $0.73 $2.19 $3.64
2022-06-21 $0.69 $2.14 $3.60
2022-06-22 $0.65 $2.10 $3.55
2022-06-23 $0.61 $2.06 $3.51
2022-06-24 $0.57 $2.02 $3.47
2022-06-27 $0.52 $1.98 $3.43
2022-06-28 $0.48 $1.93 $3.39
2022-06-29 $0.44 $1.89 $3.34
2022-06-30 $0.40 $1.85 $3.30
2022-07-01 $0.36 $1.81 $3.26
2022-07-05 $0.31 $1.77 $3.22
2022-07-06 $0.27 $1.72 $3.18
2022-07-07 $0.23 $1.68 $3.13
2022-07-08 $0.19 $1.64 $3.09

About Chimerix

Chimerix Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral antivirals in the areas of unmet medical needs in the United States. The company’s lead product candidate is brincidofovir (CMX001), a nucleotide analog, which is in Phase III clinical trials for the prevention of cytomegalovirus (CMV) in allogeneic hematopoietic cell transplant (HCT) recipients and in kidney transplant recipients, as well as to treat adeno... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT